HCPCS Codes Similar to G8585

HCPCS Codes Similar to “G8585” Code.
Anti-lipid treatment at discharge

G8586 Anti-lipid treatment contraindicated Code added date: 20100101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	G8587 No anti-lipid treatment at discharge Code added date: 20100101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
G8768 Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Code added date: 20120101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M1004 Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy) Code added date: 20190101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
PS Positron emission tomography (pet) or pet/computed tomography (ct) to inform the subsequent treatment strategy of cancerous tumors when the beneficiary's treating physician determines that the pet study is needed to inform subsequent anti-tumor strategy Code added date: 20090701 Code effective date: 20090701 TXT \| PDF \| XML \| JSON	Q0155 Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
Q0161 Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON	Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen Code added date: 20120101 Code effective date: 20120101 TXT \| PDF \| XML \| JSON
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen Code added date: 19980401 Code effective date: 19980401 TXT \| PDF \| XML \| JSON	Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen Code added date: 19980401 Code effective date: 19980401 TXT \| PDF \| XML \| JSON
Q0165 Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen Code added date: 19980401 Code effective date: 20140101 TXT \| PDF \| XML \| JSON	Q0166 Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen Code added date: 19980401 Code effective date: 20090101 TXT \| PDF \| XML \| JSON